Candidiasis (oropharyngeal).

BMJ Clin Evid

King's College London at Guy's, King's and St Thomas's Dental Institute, London, UK.

Published: March 2009

Introduction: Candida is present in the mouths of up to 60% of healthy people, but overt infection is associated with immunosuppression, diabetes, broad-spectrum antibiotics, and corticosteroid use. In most people, untreated candidiasis persists for months or years unless associated risk factors are treated or eliminated. In neonates, spontaneous cure of oropharyngeal candidiasis usually occurs after 3-8 weeks.

Methods And Outcomes: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent and treat oropharyngeal candidiasis in: adults having treatment causing immunosuppression; infants and children; people with diabetes; people with dentures; and people with HIV infection? Which treatments reduce the risk of acquiring resistance to antifungal drugs? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2008 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Results: We found 46 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antifungals (absorbed or partially absorbed, and topical absorbed/partially absorbed/non-absorbed [e.g. amphotericin B, fluconazole, itraconazole, miconazole, and nystatin]) used for intermittent or continuous prophylaxis or therapy, and denture hygiene.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907793PMC

Publication Analysis

Top Keywords

oropharyngeal candidiasis
8
systematic review
8
people
5
candidiasis
4
candidiasis oropharyngeal
4
oropharyngeal introduction
4
introduction candida
4
candida mouths
4
mouths 60%
4
60% healthy
4

Similar Publications

Spread of Mycobacterium tuberculosis (MTB) to the larynx is exceedingly rare and can be obscured by more common conditions such as laryngeal cancer or oropharyngeal candidiasis, complicating an accurate diagnosis. Risk factors for chronic laryngeal disease, such as smoking and toxin exposure, place TB infection comparatively lower for consideration on a physician's differential. However, identifying these lesions is crucial from a medical and public health perspective to prevent community spread.

View Article and Find Full Text PDF

Background: EsoCap is a thin mucoadhesive film designed to target the oesophageal mucosa. The device loaded with mometasone furoate (ESO-101) is under investigation for the treatment of eosinophilic oesophagitis (EoE).

Aims: To evaluate the efficacy, safety and tolerability of ESO-101 in patients with active EoE.

View Article and Find Full Text PDF
Article Synopsis
  • Commensal oral Candida species can turn pathogenic in people with weakened immune systems, leading to oropharyngeal candidiasis (OPC) due to various factors.
  • The study assessed several enzymatic activities (phospholipase, proteinase, hemolysin, esterase, and coagulase) and biofilm formation in 35 Candida isolates from people living with HIV experiencing OPC.
  • Results revealed that most isolates exhibited strong phospholipase and proteinase activities, with significant biofilm formation, while other enzymatic activities were less prevalent.
View Article and Find Full Text PDF

Background: Candida species are frequently isolated from the oral cavity of patients with cystic fibrosis. However, the information on the role of Candida in cystic fibrosis is scarce.

Aims: This study aimed to evaluate the prevalence, virulence profile and antifungal susceptibility of oral isolates of Candida albicans recovered from patients with cystic fibrosis.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the prevalence of Candida species causing oropharyngeal and oral candidiasis among individuals with HIV in Africa, in light of improved treatments like antiretroviral therapy and the universal test and treat (UTT) policy.
  • It analyzed data from 14 studies involving over 4,200 participants, finding that a significant majority of the Candida species isolated were C. albicans, while non-albicans species like C. glabrata and C. tropicalis were also present.
  • The research indicates a decrease in the prevalence of oropharyngeal candidiasis since the introduction of UTT, with a pooled prevalence of 48%, suggesting effective interventions, although certain challenges remain.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!